Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Discusses the main factors causing index values to move, including macro data, sentiment, and sector rotations, with practical implications.
25,483 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A domestic sting underscores how easily scams prey on seniors. Explore how the scheme worked, the red flags to watch ...
Palantir Technologies and NVIDIA expanded their collaboration to accelerate government-grade AI models, sending Palan...
Investing in biotech can be bold. This piece lays out practical scenarios for what much could $1,000 invested in Viki...
The spotlight in AI investing is shifting from screens to factories. The BOTZ ETF is positioning itself to ride a wav...
Bitcoin ended June on a sour note, marking its worst performance in four years as demand cooled and ETF outflows pers...
In 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
Ethereum edges higher ahead of a major network upgrade, with an analyst signaling potential upside as on-chain use st...
Bitcoin remains above $64,000 as markets digest ETF flows and macro headlines. Pi Network’s PI token sinks to fresh l...
Binance reports that about 70% of EU withdrawals went to self-custody wallets after the MiCA deadline, with 30% stayi...
A $250,000 SPIA promises $1,600 a month for life, but it comes with lock-in, fees, and a trade-off between predictabl...
Bitcoin rose toward the $64,000 mark after June CPI fell 0.4%, while core CPI held at 2.6%. The market roles reversed...